Molly Yang
Head of Portfolio Management at NZ Growth Capital Partners
New Zealand
Overview
Work Experience
Director
2024 - Current
Mo & Associates Limited is a consultancy committed to empowering early-stage funds and startups by delivering tailored services that drive measurable success. The firm specialises in strategic advice, fund operations and management, and commercialisation support, all underpinned by a deep understanding of market opportunities and community needs.
Operating Partner
2025
Nexus Capital is a specialist private equity fund-of-funds manager approved for Active Investor Plus (AIP) investors, focused on building portfolios that provide access to premier private capital funds in New Zealand and Australia. As an Operating Partner, I play a key leadership role in designing and executing the fund’s strategy, structuring investments, engaging with investors, and overseeing reporting. My responsibility is to ensure that the fund aligns with both migrant investor expectations and government regulatory requirements, driving value for all stakeholders.
Commercial Mentor
2024 - 2025
I serve as a mentor for KiwiNet's Emerging Innovator Programme, which provides targeted support to early-career scientists poised to become New Zealand's future innovators.
Head of Portfolio Management
2023 - 2024
NZGCP is a New Zealand Government Fund which is invested through two vehicles, a $300 million Venture Capital Fund of funds and a $50 million angel seed Fund. I manage a diverse portfolio of technology companies, from seed stage to publicly listed, providing support and facilitating connections to drive their international growth. As a senior member of the investment team and a member of the investment committee, I play a key role in strategic decision-making.
Senior Portfolio Manager
2022 - 2022
Investment Manager
2015 - 2022
I am primary responsible for managing angel fund investments and also supporting venture capital fund of funds activities and performance monitoring. My main roles include new investment opportunity screening, due diligence, deal execution, divestment and portfolio management.
Board Observer
2024 - 2024
The Clinician is a leading digital health company that helps healthcare organisations globally to create more connected, convenient and patient-centred care pathways.
Board Observer
2020 - 2022
A first-of-its-kind, cutting-edge tech company revolutionizing the world of insights with game-changing AI products. In August 2024, Yabble was sold to London AIM-listed market research company YouGov.
Board Observer
2020 - 2022
Core Schedule is the leading provider of a suite of cloud-based work roster tools for staff in emergency departments, hospitals, medical training programs, and urgent care clinics in New Zealand, Australia, and the United States.
Board Advisor
2017 - 2019
New Zealand's first Chinese-led angel fund, aims to invest in high growth Kiwi start-up companies, helping them make the most of opportunities in China. I assisted Zino defining investment strategy in NZ and established connection in the local eco-system.
Investment Consultant
2014 - 2014
Worked on the preparation of raising a venture capital co-fund between New Zealand and Taiwan focused on healthcare opportunities of benefit to child health, being the government funds as cornerstone investors.
Senior Associate
2011 - 2013
AlphaBridge Group is a boutique investment firm dedicated in investment into healthcare, biotechnology and medical device sectors in China. I was worked on deal sourcing / screening, investment documentation, due diligence, financial analysis and post-investment management, including reporting, monitoring performance, support portfolio companies for overseas development, financial control and corporate governance.